Politics

Knight Therapeutics Announces Supplemental Regulatory Submission for MINJUVI® (tafasitamab) in Brazil

Financial PostAugust 27, 2026

MONTREAL, Aug. 27, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has submitted a supplemental application to ANVISA, the Brazilian health regulatory agency, seeki…

Where this sits on TrendsMap

This story hasn’t been tied to a specific state or province yet — it sits in our Canada coverage. We hold 2152 politics stories in total, and 1273 from Financial Post.

More Politics More from Financial Post Open the map

This is a summary of reporting by Financial Post. Read the full story at the source.

Read full story

Back to home

Predictions (0)

No predictions yet on this story — be the first to start one.

Comments (0)

posting as a guest

Create a free account to comment under your own name and earn Pulse.